Drawing for PROTEOGRAPH

USPTO serial 88559974

PROTEOGRAPH

Reviewed by CopyMark Law Group

Reg. 6913417Status 700Registered
Filing date
Status date
Registration date
Nov 29, 2022
Examiner
BAGLINI, KAREN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PROTEOGRAPH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brandon P. Leahy

Brandon P. Leahy WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304-1050UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagents, enzymes, and nucleotides for scientific or medical researchACTIVE—
005Medical diagnostic reagents; reagents for use in testing proteins for medical diagnostic purposesACTIVE—
009Downloadable computer software for the analysis of proteins, proteomes, and biological data; downloadable computer software for graphing proteomes and for use in medical diagnostics; downloadable computer software for accessing and using databases and information for use in connection with research and development services in the fields of medicine, proteomics, and biotechnology; downloadable computer software for analyzing molecular and clinical data and providing personalized healthcare recommendationsACTIVE—
010Clinical research and scientific instruments, namely, proteomic sample preparation instruments for medical diagnostic useACTIVE—
042Collection and analysis of molecular and clinical data for clinical research; analysis of proteins for scientific and medical research purposes; providing temporary use of non-downloadable software for the analysis of proteins, proteomes, and biological data; providing temporary use of non-downloadable software for graphing proteomes and for use in medical diagnostics; providing temporary use of non-downloadable software for accessing databases and information for use in connection with research and development services in the fields of medicine, proteomics, and biotechnology; providing temporary use of non-downloadable software for analyzing molecular and clinical data and providing personalized healthcare recommendationsACTIVEFeb 7, 2019
044Providing healthcare informationACTIVEFeb 7, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 29, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 29, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 22, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 21, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 8, 2022SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 30, 2022IUAFUSE AMENDMENT FILED—
Aug 30, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 6, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 5, 2022EX5GSOU EXTENSION 5 GRANTED—
Aug 1, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 15, 2022EXT5SOU EXTENSION 5 FILED—
Jul 15, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 1, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 28, 2022EX4GSOU EXTENSION 4 GRANTED—
Jan 28, 2022EXT4SOU EXTENSION 4 FILED—
Jan 28, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 28, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 26, 2021EX3GSOU EXTENSION 3 GRANTED—
Jul 26, 2021EXT3SOU EXTENSION 3 FILED—
Jul 26, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 22, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 20, 2021EX2GSOU EXTENSION 2 GRANTED—
Jan 20, 2021EXT2SOU EXTENSION 2 FILED—
Jan 20, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 12, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 10, 2020EX1GSOU EXTENSION 1 GRANTED—
Feb 10, 2020EXT1SOU EXTENSION 1 FILED—
Feb 10, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 4, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 10, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 10, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 20, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 6, 2019ALIEASSIGNED TO LIE—
Nov 1, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 1, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Nov 1, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 1, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 1, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 29, 2019DOCKASSIGNED TO EXAMINER—
Aug 19, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 5, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance